Suppr超能文献

电子戒烟决策工具(葡萄牙语:Pare de Fumar Conosco)与标准护理的成本效益分析。

Electronic Decision-Making Tool for Smoking Cessation (Pare de Fumar Conosco) Versus Standard of Care: A Cost-Effectiveness Analysis.

机构信息

Technical Support Division, National Institute of Cardiology, Rio de Janeiro, Rio de Janeiro, Brazil.

Faculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.

出版信息

Value Health Reg Issues. 2024 Jul;42:100980. doi: 10.1016/j.vhri.2024.01.002. Epub 2024 Apr 26.

Abstract

OBJECTIVES

The study aimed to evaluate the cost-effectiveness of the Pare de Fumar Conosco software compared with the standard of care adopted in Brazil for the treatment of smoking cessation.

METHODS

In the cohort of smokers with multiple chronic conditions, we developed an decision tree model for the benefit measures of smoking cessation. We adopted the perspectives of the Brazilian Unified Health System and the service provider. Resources and costs were measured by primary and secondary sources and effectiveness by a randomized clinical trial. The incremental cost-effectiveness ratio (ICER) was calculated, followed by deterministic and probabilistic sensitivity analyses and deterministic and probabilistic sensitivity analyses. No willingness to pay threshold was adopted.

RESULTS

The software had a lower cost and greater effectiveness than its comparator. The ICER was dominant in all of the benefits examined (-R$2 585 178.29 to -R$325 001.20). The cost of the standard of care followed by that of the electronic tool affected the ICER of the benefit measures. In all probabilistic analyses, the software was superior to the standard of care (53.6%-82.5%).

CONCLUSION

The Pare de Fumar Conosco software is a technology that results in cost savings in treating smoking cessation.

摘要

目的

本研究旨在评估 Pare de Fumar Conosco 软件与巴西采用的戒烟标准护理相比的成本效益。

方法

在患有多种慢性病的吸烟者队列中,我们为戒烟的效益措施开发了一个决策树模型。我们采用了巴西统一卫生系统和服务提供者的观点。资源和成本通过初级和次级来源进行测量,效果通过随机临床试验进行测量。计算了增量成本效益比(ICER),然后进行了确定性和概率敏感性分析以及确定性和概率敏感性分析。未采用支付意愿阈值。

结果

软件的成本低于其对照药物,且效果更好。在所有检查的效益中,ICER 都具有优势(-R$2585178.29 至-R$325001.20)。标准护理的成本和电子工具的成本都会影响效益措施的 ICER。在所有概率分析中,软件均优于标准护理(53.6%-82.5%)。

结论

Pare de Fumar Conosco 软件是一种在治疗戒烟方面可节省成本的技术。

相似文献

1
Electronic Decision-Making Tool for Smoking Cessation (Pare de Fumar Conosco) Versus Standard of Care: A Cost-Effectiveness Analysis.
Value Health Reg Issues. 2024 Jul;42:100980. doi: 10.1016/j.vhri.2024.01.002. Epub 2024 Apr 26.
6
Strategies to improve smoking cessation rates in primary care.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.
9
10
Behavioural interventions for smoking cessation: an overview and network meta-analysis.
Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2.

本文引用的文献

1
Effectiveness of a smoking cessation decision-making electronic tool (): A randomized clinical trial.
Health Informatics J. 2022 Apr-Jun;28(2):14604582221105450. doi: 10.1177/14604582221105450.
3
Digital Patient Education and Decision Aids.
Rheum Dis Clin North Am. 2019 May;45(2):245-256. doi: 10.1016/j.rdc.2019.01.001. Epub 2019 Mar 8.
6
HEALTH TECHNOLOGY ASSESSMENT EVIDENCE ON E-HEALTH/M-HEALTH TECHNOLOGIES: EVALUATING THE TRANSPARENCY AND THOROUGHNESS.
Int J Technol Assess Health Care. 2018 Jan;34(1):87-96. doi: 10.1017/S0266462317004512. Epub 2018 Feb 19.
7
Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.
Pharmacoeconomics. 2017 Jul;35(7):673-683. doi: 10.1007/s40273-017-0508-2.
8
Cost-effectiveness thresholds: pros and cons.
Bull World Health Organ. 2016 Dec 1;94(12):925-930. doi: 10.2471/BLT.15.164418. Epub 2016 Sep 19.
9
Decision-Oriented Health Technology Assessment: One Step Forward in Supporting the Decision-Making Process in Hospitals.
Value Health. 2015 Jun;18(4):505-11. doi: 10.1016/j.jval.2015.02.002. Epub 2015 Mar 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验